Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. (2019)
Attributed to:
Standards for determining the vascular contribution to neurodegeneration
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(19)30194-1
PubMed Identifier: 30738649
Publication URI: http://europepmc.org/abstract/MED/30738649
Type: Journal Article/Review
Volume: 393
Parent Publication: Lancet (London, England)
Issue: 10175
ISSN: 0140-6736